VIDEO: FDA panel gives overwhelming support to Rhopressa approval

NEWPORT BEACH, Calif. — At the OCTANe Medical Technology Innovation Forum here, Tom Mitro, chief operating officer of Aerie Pharmaceuticals, discusses the recent FDA panel on Rhopressa for the treatment of glaucoma.

Full Story →